Research Studies
Published research on HBOT for Radiation Cystitis & Proctitis
← Browse all conditions in the PubMed Research LibraryRadiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2-3 trial. (opens PubMed in a new tab)
Oscarsson N; Müller B; Rosén A; Lodding P; Mölne J; Giglio D; Hjelle KM; Vaagbø G; Hyldegaard O; Vangedal M; Salling L; Kjellberg A; Lind F; Ettala O; Arola O; Seeman-Lodding H — The Lancet. Oncology
Plain English Summary
The RICH-ART trial found greater improvement in patient-reported urinary symptoms with HBOT than with standard care for late radiation cystitis.
Limitations & context: The trial was not blinded. Transient sight- and hearing-related adverse events were reported, and eligibility criteria limit generalization.
Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up. (opens PubMed in a new tab)
Clarke RE; Tenorio LM; Hussey JR; Toklu AS; Cone DL; Hinojosa JG; Desai SP; Dominguez Parra L; Rodrigues SD; Long RJ; Walker MB — International journal of radiation oncology, biology, physics
Plain English Summary
Patients with chronic refractory radiation proctitis showed improved healing and bowel-related quality of life after HBOT compared with initial sham treatment.
Limitations & context: This applies to selected refractory proctitis patients. The crossover design and incomplete evaluable follow-up should be considered.
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting HBOT or any treatment. Individual results may vary.